Specialty chemicals maker producing surfactants, PEG-based drug-delivery materials and safety/explosive systems.
Specialty chemicals maker producing surfactants, PEG-based drug-delivery materials and safety/explosive systems.
In one line: A niche specialty-chemicals and drug-delivery-materials maker.
Moat: narrow (IP / patents, process know-how). Proprietary PEGylation chemistry used in drug-delivery formulations is a differentiated niche.
Headquarters: Tokyo, Japan · Founded: 1929 · Employees: 4,155
Size NOF (4403.T) is a Japan Materials company (Chemicals: Specialty) with a market value of $3.60B, the 323rd largest of 1,370 Japan companies the cockpit tracks. Shares closed at ¥2,551 on 18 Nov 2026.
Performance Over six months the shares fell 10.4%, against -25.7% for the median peer and -1.4% for the Japan market (cap-weighted) — 7th highest of 21 in its peer set.
Growth Revenue grew 21.7% over the last twelve months (peer median +10.0%); the operating margin is 17.4% (peer median 12.0%).
Valuation It trades at 13.6× forward earnings against a peer median of 15.7× (8th cheapest of 21).
Price implies For today's price to make sense, revenue must grow about -7% a year for seven years (Req g). Recent delivered growth is +8%, so the hurdle is -16 pp: the price already allows for a slowdown.
Capital Return on invested capital runs 9.1 points above its cost of capital (5.0% WACC).
Next results Next results expected around 10 Feb 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | ¥288B | ¥258B | ¥238B | ¥222B | ¥218B |
| Revenue growth | — | +8% | +7% | +2% | — |
| Gross profit | ¥93.0B | ¥90.1B | ¥86.1B | ¥80.4B | ¥76.8B |
| EBITDA | ¥90.8B | ¥69.5B | ¥53.3B | ¥49.1B | ¥47.0B |
| Net income | ¥42.1B | ¥40.6B | ¥36.5B | ¥34.0B | ¥34.0B |
| Free cash flow | n/a | ¥21.5B | ¥12.6B | ¥12.2B | ¥17.1B |
| Capital expenditure | n/a | ¥14.4B | ¥16.3B | ¥17.7B | ¥6.22B |
| Total debt | ¥4.30B | ¥5.14B | ¥5.04B | ¥5.17B | ¥4.84B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| NOF 4403.T | $3.60B | -10% | +22% | 17% | 13.6× | -7.4% |
| Croda International CRDA.L | $7.07B | +29% | +3% | 16% | 24.2× | 21.0% |
| Daicel 4202.T | $2.45B | +31% | +7% | 8% | 10.9× | 4.2% |
| Evonik Industries EVK.DE | $11.1B | +27% | +2% | 10% | 12.1× | -5.6% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 4403.T | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -10.9% | -4.3% | 6th lowest of 21 |
| 6-month return | -10.4% | -25.7% | 7th highest of 21 |
| Distance from 52-week high | -25.0% | -43.8% | 7th highest of 21 |
| Revenue growth (TTM) | +21.7% | +10.0% | 6th highest of 21 |
| Operating margin | 17.4% | 12.0% | 7th highest of 21 |
| Forward P/E | 13.6× | 15.7× | 8th cheapest of 21 |
| Growth the price implies (Req g, 7 yrs) | -7.4% | 4.2% | 2nd least demanding of 17 |
| Growth delivered (Del g) | +8.4% | +10.6% | 8th lowest of 17 |
| Hurdle (Req g minus delivered) | -15.8 pp | -4.4 pp | 5th least demanding of 17 |
| ROIC minus cost of capital | +9.1 pp | +1.8 pp | 4th highest of 21 |
| EV / EBITDA | 5.7× | 9.3× | cheapest of 8 |
| Net debt / EBITDA | -0.6× | 1.4× | least indebted of 8 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| NOF 4403.T | Japan | $3.60B | -10% | +22% | 17% | 13.6× | -7.4% | +8.4% |
| Pangang Group Vanadium & Titanium Resources 000629.SZ | China | $3.60B | -26% | +6% | 4% | 57.3× | 26.1% | -3.4% |
| Do-Fluoride New Materials 002407.SZ | China | $3.62B | -42% | +69% | 7% | 33.9× | 17.3% | +17.5% |
| IMEIK Technology Development 300896.SZ | China | $3.66B | -25% | -7% | 45% | 22.4× | 17.5% | +28.0% |
| Hangzhou Oxygen Plant 002430.SZ | China | $3.70B | -16% | +16% | 11% | 19.8× | 2.2% | +8.5% |
| Bluestar Adisseo 600299.SS | China | $3.70B | -34% | +15% | 13% | 11.3× | -9.4% | +7.7% |
| Mitsubishi Gas Chemical 4182.T | Japan | $3.76B | -32% | +9% | 9% | 10.2× | n/a | n/a |
| Cathay Biotech 688065.SS | China | $3.77B | -23% | +9% | 18% | 34.3× | n/a | n/a |
| Cabot CBT | United States | $3.80B | -5% | +1% | 14% | 11.3× | -2.3% | +1.9% |
| Novoray 688300.SS | China | $3.40B | -39% | +23% | 26% | 49.8× | 45.5% | +22.6% |
| Inner Mongolia Berun Chemical 000683.SZ | China | $3.28B | -27% | +11% | 13% | 13.8× | n/a | n/a |
| Ningbo Shanshan 600884.SS | China | $3.27B | -35% | +30% | 9% | 12.2× | 2.8% | +21.3% |
| Hawkins HWKN | United States | $3.19B | -1% | +9% | 11% | 34.4× | 15.9% | +12.7% |
| GEM 002340.SZ | China | $4.12B | -35% | +2% | 7% | 14.6× | 3.5% | +24.4% |
| Hexpol HPOL-B.ST | Sweden | $3.10B | +19% | -1% | 14% | 15.2× | 2.9% | +7.6% |
| Zhejiang Sanmei Chemical Industry 603379.SS | China | $4.20B | -27% | +24% | 41% | 12.2× | 3.8% | +16.5% |
| Clariant CLN.SW | Switzerland | $4.20B | +35% | -7% | 10% | 16.3× | -3.3% | +0.3% |
| Guangxi Huaxi Nonferrous Metal 600301.SS | China | $4.27B | -25% | +24% | 32% | 22.6× | 9.1% | +44.9% |
| Guangzhou Guanggang Gases and Energy 688548.SS | China | $3.02B | -26% | +21% | 20% | 55.4× | n/a | n/a |
| Air Water 4088.T | Japan | $4.34B | +34% | +11% | 3% | 11.8× | 9.4% | +6.8% |
| Far Eastern New Century 1402.TW | Taiwan | $4.39B | +2% | +5% | 7% | 11.5× | 4.7% | +4.2% |